Acquirer | Target | Price |
---|---|---|
The Blackstone Group | TeamHealth Holdings | $6.1 billion |
Karo Pharma AB | BioPhausia AB | $101.8 million |
National Health Investors | Entrance-fee CCRC | $74 million |
Celldex Therapeutics | Koltan Pharmaceuticals | $62.5 million |
Mirgan Therapeutics | Signal Genetics | $40 million |